• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

西罗莫司:一种用于控制广泛性静脉畸形并发症的挽救性药物。

Sirolimus: A Rescue Drug to Control Complications of Extensive Venous Malformation.

作者信息

Abdelbaky Mohamed Aly, Ragab Iman Ahmed, AbouZeid Amr AbdelHamid, Mohammad Shaimaa Abdelsattar, Dahab Mohamed Moussa, Elsherbeny Mohammed, Safaan Hatem Abdelkader

机构信息

Department of Pediatric Surgery, Ain Shams University Faculty of Medicine, Cairo, Egypt.

Department of Pediatrics, Ain Shams University, Faculty of Medicine, Cairo, Egypt.

出版信息

European J Pediatr Surg Rep. 2020 Jan;8(1):e90-e94. doi: 10.1055/s-0040-1716895. Epub 2020 Dec 15.

DOI:10.1055/s-0040-1716895
PMID:33335826
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7738235/
Abstract

Venous malformations represent a major sector of vascular anomalies. Most cases are asymptomatic or subclinical; however, large extensive lesions can cause severe disability and sometimes mortality. In this report, we present a successful case of sirolimus treatment in managing an extensive venous malformation in the pelvis of a 21-month-old boy who presented with life-threatening complications. With a history dating since the day 2 of life, the patient suffered from chronic bleeding due to scrotal skin ulcerations, in addition to recurrent attacks of severe bleeding per rectum necessitating hospital admission and blood transfusion (three attacks since the age of 7 months). Pelvic magnetic resonance image showed the typical findings of extensive venous malformation involving the pelvis, perineum, scrotum, and extending to the gluteal region. The lesion was seen totally encasing the anorectum with marked thickening of their walls almost occluding their lumen. Oral sirolimus (2 mg/m ) was started with a target blood trough level of 5 to 10 ng/mL. Over a follow-up period of 5 months, there was obvious clinical improvement that included healing of skin lesions (scrotal ulcer) with complete re-epithelialization, absence of bleeding per rectum with improvement of constipation, and rise of hemoglobin level from 7.5 to 11.5 g/dL.

摘要

静脉畸形是血管异常的一个主要类型。大多数病例无症状或为亚临床状态;然而,广泛的大病灶可导致严重残疾,有时甚至危及生命。在本报告中,我们介绍了一例成功使用西罗莫司治疗一名21个月大男童盆腔广泛静脉畸形的病例,该患儿出现了危及生命的并发症。自出生第2天起,该患者除了因阴囊皮肤溃疡导致慢性出血外,还反复出现严重的直肠出血,需要住院并输血(自7个月大以来发作了3次)。盆腔磁共振成像显示了广泛静脉畸形的典型表现,累及盆腔、会阴、阴囊,并延伸至臀区。可见病变完全包裹直肠肛门,其壁明显增厚,几乎闭塞管腔。开始口服西罗莫司(2mg/m²),目标血药谷浓度为5至10ng/mL。在5个月的随访期内,临床有明显改善,包括皮肤病变(阴囊溃疡)愈合,上皮完全再生,直肠不再出血,便秘改善,血红蛋白水平从7.5g/dL升至11.5g/dL。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cf1/7738235/f743e7efe89c/10-1055-s-0040-1716895-i200528cr-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cf1/7738235/428060e8950b/10-1055-s-0040-1716895-i200528cr-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cf1/7738235/f743e7efe89c/10-1055-s-0040-1716895-i200528cr-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cf1/7738235/428060e8950b/10-1055-s-0040-1716895-i200528cr-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cf1/7738235/f743e7efe89c/10-1055-s-0040-1716895-i200528cr-2.jpg

相似文献

1
Sirolimus: A Rescue Drug to Control Complications of Extensive Venous Malformation.西罗莫司:一种用于控制广泛性静脉畸形并发症的挽救性药物。
European J Pediatr Surg Rep. 2020 Jan;8(1):e90-e94. doi: 10.1055/s-0040-1716895. Epub 2020 Dec 15.
2
Sirolimus (Rapamycin) for Slow-Flow Malformations in Children: The Observational-Phase Randomized Clinical PERFORMUS Trial.西罗莫司(雷帕霉素)治疗儿童慢血流畸形:PERFORMUS 试验的观察阶段随机临床试验。
JAMA Dermatol. 2021 Nov 1;157(11):1289-1298. doi: 10.1001/jamadermatol.2021.3459.
3
Sirolimus is efficacious in treatment for extensive and/or complex slow-flow vascular malformations: a monocentric prospective phase II study.西罗莫司治疗广泛和/或复杂慢血流血管畸形有效:单中心前瞻性 II 期研究。
Orphanet J Rare Dis. 2018 Oct 29;13(1):191. doi: 10.1186/s13023-018-0934-z.
4
Endorectal pull-through abates gastrointestinal hemorrhage from colorectal venous malformations.经直肠拖出术可减轻结直肠静脉畸形引起的胃肠道出血。
J Pediatr Surg. 2000 Jun;35(6):982-4. doi: 10.1053/jpsu.2000.6947.
5
Extensive venous/lymphatic malformations causing life-threatening haematological complications.广泛的静脉/淋巴管畸形导致危及生命的血液学并发症。
Br J Dermatol. 2007 Sep;157(3):558-63. doi: 10.1111/j.1365-2133.2007.08003.x. Epub 2007 Jun 15.
6
Surgical Treatment of Intra-articular Knee Venous Malformations: When and How?膝关节内静脉畸形的外科治疗:时机与方式?
J Pediatr Orthop. 2016 Apr-May;36(3):316-22. doi: 10.1097/BPO.0000000000000432.
7
Oral Propranolol in the Treatment of Ulcerated Bleeding Scrotal Arteriovenous Malformation.口服普萘洛尔治疗溃疡性出血性阴囊动静脉畸形
J Indian Assoc Pediatr Surg. 2020 Nov-Dec;25(6):401-403. doi: 10.4103/jiaps.JIAPS_232_19. Epub 2020 Oct 27.
8
[Preliminary investigation on embolization of orbital vascular malformation with medical glue injection intraoperatively].[术中注射医用胶水栓塞眼眶血管畸形的初步研究]
Zhonghua Yan Ke Za Zhi. 2018 Jul 11;54(7):502-508. doi: 10.3760/cma.j.issn.0412-4081.2018.07.007.
9
Treatment of voluminous and complicated superficial slow-flow vascular malformations with sirolimus (PERFORMUS): protocol for a multicenter phase 2 trial with a randomized observational-phase design.西罗莫司治疗巨大复杂浅表性慢血流血管畸形(PERFORMUS):一项采用随机观察阶段设计的多中心2期试验方案
Trials. 2018 Jun 27;19(1):340. doi: 10.1186/s13063-018-2725-1.
10
Oral Sirolimus: An Option in the Management of Neonates with Life-Threatening Upper Airway Lymphatic Malformations.口服西罗莫司:治疗危及生命的新生儿上气道淋巴管畸形的一种选择。
Lymphat Res Biol. 2019 Oct;17(5):504-511. doi: 10.1089/lrb.2018.0068. Epub 2019 Apr 13.

引用本文的文献

1
Successful Sirolimus Treatment for Recurrent Pericardial Effusion in a Large Cervicomediastinal Provisionally Unclassified Vascular Anomaly: A Case Report.西罗莫司成功治疗一例大型颈纵隔暂未分类血管异常伴复发性心包积液:病例报告
European J Pediatr Surg Rep. 2023 May 17;11(1):e20-e24. doi: 10.1055/a-2057-7177. eCollection 2023 Jan.
2
Deep vein thrombosis in the setting of Klippel-Trenaunay syndrome and sirolimus treatment.克-特综合征及西罗莫司治疗背景下的深静脉血栓形成
J Vasc Surg Cases Innov Tech. 2021 Jul 17;7(3):524-528. doi: 10.1016/j.jvscit.2021.06.014. eCollection 2021 Sep.

本文引用的文献

1
Effectiveness of sirolimus in the treatment of complex lymphatic malformations: Single center report of 56 cases.西罗莫司治疗复杂淋巴管畸形的疗效:单中心 56 例报告。
J Pediatr Surg. 2020 Nov;55(11):2454-2458. doi: 10.1016/j.jpedsurg.2019.12.021. Epub 2020 Jan 29.
2
Practical Genetic and Biologic Therapeutic Considerations in Vascular Anomalies.血管异常的实用遗传与生物学治疗考量
Tech Vasc Interv Radiol. 2019 Dec;22(4):100629. doi: 10.1016/j.tvir.2019.100629. Epub 2019 Sep 21.
3
Efficacy and safety of sirolimus in the treatment of vascular anomalies: A systematic review.
西罗莫司治疗血管异常的疗效和安全性:系统评价。
J Vasc Surg. 2020 Jan;71(1):318-327. doi: 10.1016/j.jvs.2019.06.217. Epub 2019 Oct 30.
4
Effect of sirolimus on coagulopathy of slow-flow vascular malformations.西罗莫司对低流速血管畸形凝血功能障碍的影响。
Pediatr Blood Cancer. 2019 Oct;66(10):e27896. doi: 10.1002/pbc.27896. Epub 2019 Jun 28.
5
The impact of sirolimus therapy on lesion size, clinical symptoms, and quality of life of patients with lymphatic anomalies.西罗莫司治疗对淋巴管畸形患者病变大小、临床症状和生活质量的影响。
Orphanet J Rare Dis. 2019 Jun 13;14(1):141. doi: 10.1186/s13023-019-1118-1.
6
Sirolimus is efficacious in treatment for extensive and/or complex slow-flow vascular malformations: a monocentric prospective phase II study.西罗莫司治疗广泛和/或复杂慢血流血管畸形有效:单中心前瞻性 II 期研究。
Orphanet J Rare Dis. 2018 Oct 29;13(1):191. doi: 10.1186/s13023-018-0934-z.
7
Soft-tissue vascular malformations and tumors. Part 2: low-flow lesions.软组织血管畸形与肿瘤。第2部分:低流量病变。
Radiologia (Engl Ed). 2019 Mar-Apr;61(2):124-133. doi: 10.1016/j.rx.2018.02.012. Epub 2018 Oct 3.
8
Treatment of Venous Malformations: The Data, Where We Are, and How It Is Done.静脉畸形的治疗:数据、现状及治疗方法
Tech Vasc Interv Radiol. 2018 Jun;21(2):45-54. doi: 10.1053/j.tvir.2018.03.001. Epub 2018 Mar 8.
9
Late sequelae and long-term outcomes of vascular anomalies.血管畸形的晚期后遗症及长期预后
Semin Pediatr Surg. 2017 Oct;26(5):317-321. doi: 10.1053/j.sempedsurg.2017.09.007. Epub 2017 Sep 9.
10
Germline Loss-of-Function Mutations in EPHB4 Cause a Second Form of Capillary Malformation-Arteriovenous Malformation (CM-AVM2) Deregulating RAS-MAPK Signaling.胚系 EPHB4 功能丧失性突变导致第二种毛细血管畸形-动静脉畸形(CM-AVM2),该疾病失调 RAS-MAPK 信号通路。
Circulation. 2017 Sep 12;136(11):1037-1048. doi: 10.1161/CIRCULATIONAHA.116.026886. Epub 2017 Jul 7.